Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v14-FR
Language French French
Date Updated 2020-09-17 2020-09-17
Drug Identification Number 02308746 02308746
Brand name TEVA-SILDENAFIL TEVA-SILDENAFIL
Common or Proper name SILDENAFIL 50MG TAB SILDENAFIL 50MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients SILDENAFIL SILDENAFIL
Strength(s) 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size P Pack 4 P Pack 4
ATC code G04BE G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-04-29 2020-04-29
Estimated end date 2020-09-30 2020-09-30
Actual end date 2020-09-16 2020-09-16
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments